Multi-antigen therapeutic HIV DNA vaccine

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMulti-antigen therapeutic HIV DNA vaccine
Drug Alias NamePBX Vax prime/boost HIVHIV MAG pDNA vaccineProfectusVaxVSV IN HIV envCProfectusVax DNA Plasmid HIV-1 nef/tat/vif env
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Application > Therapeutic vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAuro Vaccines Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAuro Vaccines LlcNational Institute Of Allergy And Infectious Diseases (Niaid)
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A